Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...

A day after the warning landed on semaglutide labels, Novo Nordisk CEO Lars Fruergaard Jørgensen said he is alarmed by the amount of unsafe compounded GLP-1s in the U.S. market, adding that the ...

Stepping into this turbulent environment is Novo Nordisk’s new CEO Lars Fruergaard Jørgensen. A 25-year insider at Novo Nordisk, Jørgensen took the helm in January this year, and brought in ...

After the 2024 U.S. election, Vermont Senator Bernie Sanders delivered a sharp critique of the Democratic party, asserting ...

“The agreement to acquire the three Catalent manufacturing sites […] will enable us to serve significantly more people living with diabetes and obesity in the future,” said Lars Fruergaard ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Novo Nordisk President and CEO Lars Fruergaard Jorgensen, shown testifying on Capitol Hill in September, is warning about potential risks from compounded versions of the drug semaglutide.

Four leaders from U.S.-based healthcare organizations were featured in Fortune's "100 Most Powerful People in Business" list, released Nov. 12. Fortune editors scored candidates based on metrics ...

Regeringens nye life science-strategi vil styrke den danske nøglesektors konkurrenceevne. Den bør inspirere et udfordret ...

The Copenhagen Police warns against scanning QR codes that are appearing around the city, as many of them redirect users to websites where people are asked to enter their payment ...

“Honestly, I’m quite alarmed by what we see in the US now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen told CNN. “Patients who believe that they’re getting access to a safe ...